Concepedia

Author

Isabelle Pilatte

Johnson & Johnson (France)

Also Known As

I. Pilatte, Isabelle Pilatte

16

Publications

367

Citations

8

H-Index

11

Concepts

All Affiliations

Johnson & Johnson (France)Johnson & Johnson (United States)SpringhouseAZ Turnhout
IP

About

Isabelle Pilatte is an author at Johnson & Johnson (France) specializing in drug discovery, medicine, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

115

2

Pharmacology

5

5

115

3

Natural Sciences

4

4

86

4

Biochemistry

4

4

79

5

Chemical Biology

3

3

50

Isabelle Pilatte

×

6

Publications

345

Citations

6

H-Index

YearCitations

JNJ-26481585, a Novel Second-Generation Oral Histone Deacetylase Inhibitor, Shows Broad-Spectrum Preclinical Antitumoral Activity

Janine Arts, Peter King, Ann Marin,

Clinical Cancer Research

2009

230

5-Imidazolyl-quinolinones, -quinazolinones and -benzo-azepinones as farnesyltransferase inhibitors

Patrick Angibaud, Xavier Bourdrez, Ann Devine,

Bioorganic & Medicinal Chemistry Letters

2003

36

Substituted azoloquinolines and -quinazolines as new potent farnesyl protein transferase inhibitors

Patrick Angibaud, Xavier Bourdrez, David W. End,

Bioorganic & Medicinal Chemistry Letters

2003

29

Identification of a series of substituted 2-piperazinyl-5-pyrimidylhydroxamic acids as potent histone deacetylase inhibitors

Patrick Angibaud, Kristof Van Emelen, Laurence Decrane,

Bioorganic & Medicinal Chemistry Letters

2009

18

Discovery of pyrimidyl-5-hydroxamic acids as new potent histone deacetylase inhibitors

Patrick Angibaud, Janine Arts, Kristof Van Emelen,

European Journal of Medicinal Chemistry

2005

16

4-Methyl-1,2,4-triazol-3-yl heterocycle as an alternative to the 1-methylimidazol-5-yl moiety in the Farnesyltransferase inhibitor ZARNESTRA ™

Patrick Angibaud, Ashis Saha, Xavier Bourdrez,

Bioorganic & Medicinal Chemistry Letters

2003

16

Page 1